证券记录 · 已归档季度
SLDB
Solid Biosciences Inc. · Healthcare · Biotechnology
17被追踪持有人
+1Δ持有人
23.96M持有股份
$147.82M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 -11.3% ·
净新建仓位 +5.9%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | +6 | 45.63M | $455.47M | +9 | −3 |
| Q1 2026 | 69 | 0 | 38.87M | $279.42M | +3 | −3 |
| Q4 2025 | 68 | +2 | 30.07M | $169.59M | +2 | — |
| Q3 2025 | 17 | +1 | 23.96M | $147.82M | +1 | — |
| Q2 2025 | 13 | -1 | 26.02M | $126.70M | +1 | −2 |
| Q1 2025 | 11 | +1 | 11.02M | $40.79M | +3 | −2 |
| Q4 2024 | 10 | -1 | 4.93M | $19.74M | +1 | −2 |
| Q3 2024 | 10 | +1 | 5.36M | $37.37M | +1 | — |
| Q2 2024 | 9 | — | 5.20M | $29.49M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 4.73M | -4.0% | $29.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 4.00M | -40.6% | $24.68M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 3.08M | -8.4% | $19.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 3.08M | -8.4% | $19.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 3.08M | -8.4% | $19.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.91M | -8.3% | $17.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.91M | -8.3% | $17.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 2.59M | +2.8% | $16.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 2.59M | +2.8% | $16.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 1.33M | +5.3% | $8.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Geode Capital Management ✦ (被动) | 1.29M | -14.8% | $7.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (被动) | 1.29M | -14.8% | $7.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (被动) | 1.09M | +14.9% | $6.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Millennium Management ✦ | 909.70K | -17.2% | $5.61M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 676.63K | — | $4.17M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 676.63K | — | $4.17M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 463.70K | 新增 | $2.86M | 0.0% | New | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 257.85K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Wellington Management ✦ | 226.40K | +66.8% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Wellington Management ✦ | 226.40K | +66.8% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Wellington Management ✦ | 226.40K | +66.8% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 155.85K | -10.4% | $961,595 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 131.06K | +0.8% | $808,622 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 131.06K | +0.8% | $808,622 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 131.06K | +0.8% | $808,622 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 131.06K | +0.8% | $808,622 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 71.41K | — | $440,574 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 35.09K | +6.1% | $217,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $2.86M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 137 持有人, 96.05M 股份, $689.27M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据